A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP Inhibitor
PHASE2
To evaluate the efficacy and safety of JPI-547, a PARP/TNKS dual inhibitor ...
Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer
PHASE1
The purpose of this study is to assess the safety, tolerability and efficac...